相似文献
1
A controlled trial of antihypertensive therapy in systemic sclerosis (scleroderma).
Ann Rheum Dis. 1984 Jun;43(3):407-10. doi: 10.1136/ard.43.3.407.
2
The effects of antihypertensive therapy on the quality of life.
N Engl J Med. 1986 Jun 26;314(26):1657-64. doi: 10.1056/NEJM198606263142602.
3
[Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
Schweiz Med Wochenschr. 1983 Mar 5;113(9):331-8.
4
The position of beta-blockers in antihypertensive therapy. Comparison with other antihypertensive agents.
Cardiology. 1979;64 Suppl 1:88-95. doi: 10.1159/000170653.
5
Ketanserin in the treatment of systemic sclerosis: a double-blind controlled trial.
Br J Dermatol. 1989 Feb;120(2):261-6. doi: 10.1111/j.1365-2133.1989.tb07791.x.
6
Sexual symptoms in hypertensive patients. A clinical trial of antihypertensive medications.
Arch Intern Med. 1988 Apr;148(4):788-94.
7
[Comparison between propranolol and methyldopa in the treatment of hypertension (a double-blind trial)].
Ugeskr Laeger. 1973 May 17;135(20):974-6.
8
Comparison of prazosin and methyldopa in essential hypertension: results of a randomized, double-blind, parallel trial.
J Cardiovasc Pharmacol. 1979 Nov-Dec;1(6 Suppl):S28-37.
9
Methyldopa and propranolol or practolol in moderate hypertension.
Br Med J. 1976 Jul 17;2(6028):137-9. doi: 10.1136/bmj.2.6028.137.
10
Renal involvement in progressive systemic sclerosis: prolonged survival with aggressive antihypertensive management.
Arthritis Rheum. 1979 Oct;22(10):1132-4. doi: 10.1002/art.1780221013.
引用本文的文献
1
Scleroderma renal crisis.
J Clin Hypertens (Greenwich). 2003 Mar-Apr;5(2):168-70, 176. doi: 10.1111/j.1524-6175.2003.01928.x.
2
ARAMIS (the American Rheumatism Association Medical Information System). A prototypical national chronic-disease data bank.
West J Med. 1986 Dec;145(6):798-804.
3
Systemic sclerosis: is there a treatment yet?
Ann Rheum Dis. 1990 Sep;49(9):735-7. doi: 10.1136/ard.49.9.735.
4
Treatment of systemic sclerosis.
Ann Rheum Dis. 1991 Nov;50 Suppl 4(Suppl 4):877-86. doi: 10.1136/ard.50.suppl_4.877.
本文引用的文献
1
Slow progress with scleroderma.
Ann Intern Med. 1982 Nov;97(5):776-8. doi: 10.7326/0003-4819-97-5-776.
2
D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis.
Ann Intern Med. 1982 Nov;97(5):652-9. doi: 10.7326/0003-4819-97-5-652.
3
Intra-arterially administered reserpine and saline in scleroderma.
Arch Intern Med. 1974 Sep;134(3):515-8.
4
Hemodialysis and kidney transplantation for renal failure from scleroderma.
Arthritis Rheum. 1973 Mar-Apr;16(2):265-71. doi: 10.1002/art.1780160220.
5
Resolution of cutaneous manifestations of systemic sclerosis after haemodialysis.
Br Med J. 1976 Feb 28;1(6008):501. doi: 10.1136/bmj.1.6008.501.
6
Pathogenesis of systemic sclerosis: a vascular hypothesis.
Semin Arthritis Rheum. 1975 May;4(4):351-68. doi: 10.1016/0049-0172(75)90017-7.
7
Is elevated plasma renin activity of prognostic importance in progressive systemic sclerosis?
Arch Intern Med. 1977 Nov;137(11):1554-8.
8
Successful medical treatment of scleroderma renal crisis.
N Engl J Med. 1978 Oct 19;299(16):873-5. doi: 10.1056/NEJM197810192991607.
9
The microvascular pathogenesis of scleroderma: an hypothesis.
Ann Intern Med. 1979 Nov;91(5):788-9. doi: 10.7326/0003-4819-91-5-788.
10
The management of renal scleroderma: experience with dialysis, nephrectomy and transplantation.
Am J Med. 1978 Jun;64(6):974-8. doi: 10.1016/0002-9343(78)90452-7.
Zotero 插件